The Impact of CAROtid plaque Screening on Smoking (CAROSS) cessation and control of other cardiovascular risk factors: Rationale and design of a randomized controlled trial

Contemporary Clinical Trials

Volumn 29, Issue 5, 2008, Pages 767-773

  Rodondi, Nicolas ^a   Bovet, Pascal ^b   Hayoz, Daniel ^c   Cornuz, Jacques ^a  

^a Department of Ambulatory Care and Community Medicine ^*  (Switzerland)

^b Institute of Social and Preventive Medicine   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Atherosclerosis; Cardiovascular; Clinical trial; Diagnostic techniques; Health behavior; Smoking cessation; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PREVENTION AND CONTROL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCREENING; SMOKING; SMOKING CESSATION;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 49749096556     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2008.03.001     Document Type: Article

References (43)

1. Greenland P. Improving risk of coronary heart disease: can a picture make the difference?. Jama 289 17 (2003) 2270-2272
2. Greenland P., Smith Jr. S.C., and Grundy S.M. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 104 15 (2001) 1863-1867
3. NHLBI: Determining the role of subclinical disease testing in patients at intermediate risk: Report of the Working Group (2004)
4. Smith Jr. S.C., Greenland P., and Grundy S.M. AHA Conference Proceedings. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation 101 1 (2000) 111-116
5. Pignone M., Fowler-Brown A., Pletcher M.J., and Tice J. Screening for asymptomatic coronary artery disease: a systematic review for the U.S. Preventive Services Task Force vol Access on August 2005 (2003), Agency for Healthcare Research and Quality, Rockville, MD
6. Screening for coronary heart disease: recommendation statement. Ann Intern Med 140 7 (2004) 569-572
7. Wilson P.W., Smith Jr. S.C., Blumenthal R.S., Burke G.L., and Wong N.D. 34th Bethesda Conference: task force #4-How do we select patients for atherosclerosis imaging?. J Am Coll Cardiol 41 11 (2003) 1898-1906
8. Weinstein N.D., Marcus S.E., and Moser R.P. Smokers' unrealistic optimism about their risk. Tob Control 14 1 (2005) 55-59
9. Bize R., Burnand B., Mueller Y., and Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 4 (2005) CD004705
10. Bovet P., Perret F., Cornuz J., Quilindo J., and Paccaud F. Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques. Prev Med 34 2 (2002) 215-220
11. O'Malley P.G., Rupard E.J., Jones D.L., Feuerstein I., Brazaitis M., and Taylor A.J. Does the diagnosis of coronary calcification with electron beam computed tomography motivate behavioral change in smokers?. Mil Med 167 3 (2002) 211-214
12. O'Malley P.G., Feuerstein I.M., and Taylor A.J. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. Jama 289 17 (2003) 2215-2223
13. DeBusk R.F., Miller N.H., Superko H.R., et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 120 9 (1994) 721-729
14. Rigotti N.A., Singer D.E., Mulley Jr. A.G., and Thibault G.E. Smoking cessation following admission to a coronary care unit. J Gen Intern Med 6 4 (1991) 305-311
15. West R., Hajek P., Stead L., and Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 100 3 (2005) 299-303
16. Jorenby D.E., Hays J.T., Rigotti N.A., et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296 1 (2006) 56-63
17. Altman D.G., Schulz K.F., Moher D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 8 (2001) 663-694
18. Enquête suisse sur la santé (2002), Office fédéral de la statistique
19. Cigarette smoking among adults-United States, 2003. Jama 294 2 (2005) 172-173
20. Rodondi N., Auer R., Devine P., O'Malley P., Hayoz D., and Cornuz J. The impact of carotid plaque screening on motivation for smoking cessation. Nicotine Tob Res 10 3 (2008) 541-546
21. The health benefits of smoking cessation. A report of the Surgeon General, Washington, DC: U.S. Department of Health and Human Services. DHHS Publication (CDC) 90-8416. vol Access on September 29, 2005 (1990)
22. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama 289 19 (2003) 2560-2572
23. NCEP: EXECUTIVE SUMMARY of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama 285 19 (2001) 2486-2497
24. Standards of medical care in diabetes. Diabetes Care 28 suppl_1 (2005) S4-S36
25. Cornuz J., Humair J.P., Seematter L., et al. Efficacy of resident training in smoking cessation: a randomized, controlled trial of a program based on application of behavioral theory and practice with standardized patients. Ann Intern Med 136 6 (2002) 429-437
26. Wong N.D., Detrano R.C., Diamond G., et al. Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors?. Am J Cardiol 78 11 (1996) 1220-1223
27. Redberg R.F., Vogel R.A., Criqui M.H., Herrington D.M., Lima J.A., and Roman M.J. 34th Bethesda Conference: Task force #3-What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?. J Am Coll Cardiol 41 11 (2003) 1886-1898
28. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156 9 (2002) 871-881
29. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson Jr. S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 1 (1999) 14-22
30. van der Meer I.M., Bots M.L., Hofman A., del Sol A.I., van der Kuip D.A., and Witteman J.C. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 109 9 (2004) 1089-1094
31. Salonen J.T., and Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 11 5 (1991) 1245-1249
32. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis 18 4 (2004) 346-349
33. Cohen S., Kamarck T., and Mermelstein R. A global measure of perceived stress. J Health Soc Behav 24 4 (1983) 385-396
34. Hurt R.D., Sachs D.P., Glover E.D., et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337 17 (1997) 1195-1202
35. Silagy C., Lancaster T., Stead L., Mant D., and Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3 (2004) CD000146
36. Rigotti N.A. Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 346 7 (2002) 506-512
37. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 9061 (1997) 1269-1276
38. Rodgers A., Ezzati M., Vander Hoorn S., Lopez A.D., Lin R.B., and Murray C.J. Distribution of major health risks: findings from the global burden of disease study. PLoS Med 1 1 (2004) e27
39. Greenland P., Knoll M.D., Stamler J., et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. Jama 290 7 (2003) 891-897
40. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 18 (1998) 1837-1847
41. Rodondi N., Peng T., Karter A.J., et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med 144 7 (2006) 475-484
42. Grundy S.M., Bazzarre T., Cleeman J., et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation 101 1 (2000) E3-E11
43. Cornuz J., Gilbert A., Pinget C., et al. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison. Tob Control 15 3 (2006) 152-159